116 results
Page 4 of 6
8-K
EX-2.1
024hj1p3 6le5jwwj
29 Jan 19
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
8:16am
424B5
crihlv9
28 Dec 18
Prospectus supplement for primary offering
4:19pm
8-K
EX-10.1
9x98kq2g1
28 Dec 18
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-1.1
vcl8ca8xlxe9
28 Sep 18
Aldeyra Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
4:50pm
424B5
vvnqm0f hmq
28 Sep 18
Prospectus supplement for primary offering
4:34pm
8-K
EX-99.2
g9ctlj9a3y8 j0o34ld4
25 Sep 18
Aldeyra Therapeutics Announces Positive Mesothelioma Investigator-Sponsored Clinical Trial Results
8:17am
8-K
8bfwk
8 Jun 18
Submission of Matters to a Vote of Security Holders
4:31pm
DEFA14A
n9uiek4qxb
25 Apr 18
Additional proxy soliciting materials
5:25pm